The hair follicle is composed primarily of epithelial and dermal components which develop from embryonic ectoderm and mesoderm respectively. Hair growth cycle as well as hair follicle morphogenesis are coordinated and complex processes that are dependent on the interactions of epithelial and dermal components. Over the past decade, many genes such as hairless, nude, sonic hedgehog, β-catenin etc. have been identified as morphogenic molecules, and several gene families are particularly important to hair cycle control, namely, TGF-β, FGFs, IGF-I (insulin-like growth factor-I), and EGF families. EGF receptor signaling has been found to play an important role in catagen induction by the experiments of transgenic mouse models. STAT 3 is a down stream signaling molecule of cytokines, growth factors including EGF and HGF. Conditional gene targeting of STAT3 in mice showed severely compromised hair cycle and wound healing processes. Growth factor-dependent
in vitro migration of the STAT3-disrupted keratinocytes was impaired despite normal proliferative responses. STAT3 plays a crucial role in skin remodeling, that is, anagen induction and wound healing. One of the typical example of the signal transduction in the cell is androgen-androgen receptor system. Androgen receptor, ligand dependent transcription factor, is apparently involved in hair cycle control in human. Beard, axillary and frontal scalp dermal papilla cells (DPC) strongly expressed androgen receptor mRNA. While the expression of type I 5α-reductase is ubiquitous property of DPC, type II 5α-reductase gene expression is limited to beard and frontal scalp DPC. Androgen significantly stimulated the proliferation of follicular epithelial cells cocultured with beard or axillary DPC, suggesting that these DPC produce androgen-dependent diffusible growth factors. IGF-I was identified as one of the androgen dependent paracrine growth factors in DPC. On the contrary, frontal scalp DPC of stumptailed macaque inhibit the growth of follicular epithelial cells in an androgen dependent manner. It should be clarified whether inhibition or production of growth factors inhibitors are involved in these effects. Finasteride that is a potent type II 5α-reductase inhibitor is a new treatment for androgenetic alopecia and minoxidil is currently avairable in Japan. New approach to control transcripitonal activity of genes involved in hair cycle will extend further treatment options.
View full abstract